BACKGROUND: Loneliness and social isolation are significant public health problems that are being exacerbated during the coronavirus disease 2019 pandemic. Little is known about the associations between loneliness and symptom burden in oncology patients before and during the pandemic. Study purposes include determining the prevalence of loneliness in a sample of oncology patients; evaluating for differences in demographic, clinical, and symptom characteristics between lonely and nonlonely patients; and determining which demographic, clinical, and symptom characteristics were associated with membership in the lonely group. METHODS: A convenience sample (n = 606) completed online surveys that evaluated the severity of loneliness, social isolation, and common symptoms (ie, anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain) in oncology patients. Parametric and nonparametric tests were used to evaluate for differences in scores between the lonely and nonlonely groups. Logistic regression analysis was used to determine risk factors for membership in the loneliness group. RESULTS: Of the 606 patients, 53.0% were categorized in the lonely group. The lonely group reported higher levels of social isolation, as well as higher symptom severity scores for all of the symptoms evaluated. In the multivariate model, being unmarried, having higher levels of social isolation, as well as higher levels of anxiety and depressive symptoms were associated with membership in the lonely group. CONCLUSIONS: Study findings suggest that a significant number of oncology patients are experiencing loneliness, most likely as a result of mandate social distancing and isolation procedures. The symptom burden of these patients is extremely high and warrants clinical evaluation and interventions.
BACKGROUND: Loneliness and social isolation are significant public health problems that are being exacerbated during the coronavirus disease 2019 pandemic. Little is known about the associations between loneliness and symptom burden in oncology patients before and during the pandemic. Study purposes include determining the prevalence of loneliness in a sample of oncology patients; evaluating for differences in demographic, clinical, and symptom characteristics between lonely and nonlonely patients; and determining which demographic, clinical, and symptom characteristics were associated with membership in the lonely group. METHODS: A convenience sample (n = 606) completed online surveys that evaluated the severity of loneliness, social isolation, and common symptoms (ie, anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain) in oncology patients. Parametric and nonparametric tests were used to evaluate for differences in scores between the lonely and nonlonely groups. Logistic regression analysis was used to determine risk factors for membership in the loneliness group. RESULTS: Of the 606 patients, 53.0% were categorized in the lonely group. The lonely group reported higher levels of social isolation, as well as higher symptom severity scores for all of the symptoms evaluated. In the multivariate model, being unmarried, having higher levels of social isolation, as well as higher levels of anxiety and depressive symptoms were associated with membership in the lonely group. CONCLUSIONS: Study findings suggest that a significant number of oncology patients are experiencing loneliness, most likely as a result of mandate social distancing and isolation procedures. The symptom burden of these patients is extremely high and warrants clinical evaluation and interventions.
Authors: Lisa M Jaremka; Christopher P Fagundes; Ronald Glaser; Jeanette M Bennett; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2012-12-27 Impact factor: 4.905
Authors: Julie Christiansen; Rikke Lund; Pamela Qualter; Christina Maar Andersen; Susanne S Pedersen; Mathias Lasgaard Journal: Ann Behav Med Date: 2021-03-20
Authors: William D S Killgore; Sara A Cloonan; Emily C Taylor; Michael A Miller; Natalie S Dailey Journal: Psychiatry Res Date: 2020-08-17 Impact factor: 3.222
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Cassandra A Hathaway; Amanda M Bloomer; Laura B Oswald; Erin M Siegel; Anita R Peoples; Cornelia M Ulrich; Frank J Penedo; Shelley S Tworoger; Brian D Gonzalez Journal: Health Psychol Date: 2022-04 Impact factor: 5.556
Authors: Kaitlyn Howden; Adam P Yan; Camille Glidden; Razvan G Romanescu; Ian Scott; Julie M Deleemans; Karine Chalifour; Geoff Eaton; Abha A Gupta; James M Bolton; Sheila N Garland; Alyson L Mahar; Sapna Oberoi Journal: Support Care Cancer Date: 2021-10-27 Impact factor: 3.603
Authors: Mei Rosemary Fu; Melissa L McTernan; Jeanna M Qiu; Christine Miaskowski; Yvette P Conley; Eunjung Ko; Deborah Axelrod; Amber Guth; Tamara J Somers; Lisa J Wood; Yao Wang Journal: Integr Cancer Ther Date: 2022 Jan-Dec Impact factor: 3.077